SERNOVA CORP.

LONDON, A6 · Biotech · Public

Cell encapsulation device for regenerative therapy of type 1 diabetes

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · sernova.com

Sector: Biotech
Headquarters: LONDON, A6
Latest Form D: $473K, Sep 2024
Total capital: $737K

Federal grants: None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised: $737K; 7 Form D · last Sep 2024; 25 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; first 2021; Rank in peer group#4 of 32

Capital timeline

Latest events

Sep 2024Private capital raisedForm D · SEC · 7th filing$473K
Oct 2020Private capital raisedForm D · SEC · 6th filing$19K
Sep 2019Private capital raisedForm D · SEC · 5th filing$100K
Jul 2016Private capital raisedForm D · SEC · 4th filing$11K
Apr 2012Private capital raisedForm D · SEC · 3rd filing$85K
Jun 2010Private capital raisedForm D · SEC · 2nd filing$20K
May 2010Private capital raisedForm D · SEC · 1st filing$30K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 32 peers

Line = median

Biotech · Device

Granted patents#4 · top 13%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

ANNEMARIE M MOSELEYDirectorNamed in SEC Form D filings
Bernd MuehlenwegDirectorNamed in SEC Form D filings
BRUCE M WEBERDirectorNamed in SEC Form D filings
David SwetlowExecutive OfficerNamed in SEC Form D filings
Deborah M. BrownDirectorNamed in SEC Form D filings
Frank A. HollerDirectorNamed in SEC Form D filings

Show all 20 people

FRANK M HOLLERDirectorNamed in SEC Form D filings
GEORGE ADAMSDirectorNamed in SEC Form D filings
G. WILLIAM M SMETHURSTExecutive OfficerNamed in SEC Form D filings
HANS M MADERDirectorNamed in SEC Form D filings
JAMES M PARSONSDirectorNamed in SEC Form D filings
Jeffrey A. BachaDirectorNamed in SEC Form D filings
JEFFREY M BACHADirectorNamed in SEC Form D filings
Jonathan RigbyExecutive Officer, DirectorNamed in SEC Form D filings
Modestus T. ObochiExecutive OfficerNamed in SEC Form D filings
Nicholas RossettosExecutive OfficerNamed in SEC Form D filings
Philip ToleikisExecutive Officer, DirectorNamed in SEC Form D filings
RALPH M DEITERDINGExecutive OfficerNamed in SEC Form D filings
Sean HodginsExecutive OfficerNamed in SEC Form D filings
Steven T. SanghaDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 2

Apr 11, 2023GrantedConformal Coating Of Cells For ImmunoisolationUSPTOUS 11,623,021
Dec 28, 2021GrantedConformal Coating Of Cells For ImmunoisolationUSPTOUS 11,207,444

PA Options for Wellness, Inc.Similar federal contract value in Biotech · null in contracts
BRT Biotechnologies, Inc.Similar federal contract value in Biotech · null in contracts
Vogenx, Inc.Similar federal contract value in Biotech · null in contracts
BioSolution Designs, Inc.Similar federal contract value in Biotech · null in contracts
TBT Pharma, Inc.Similar federal contract value in Biotech · null in contracts
Turbine Corporate Holdings, Inc.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.